- Home
- NXTC vs PC Comparison
NXTC vs PC Comparison
Compare NXTC & PC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- PC
- Stock Information
- Founded
- NXTC 2015
- PC 2012
- Country
- NXTC United States
- PC Singapore
- Employees
- NXTC N/A
- PC N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- PC Restaurants
- Sector
- NXTC Health Care
- PC Consumer Discretionary
- Exchange
- NXTC Nasdaq
- PC Nasdaq
- Market Cap
- NXTC 13.9M
- PC 11.7M
- IPO Year
- NXTC 2019
- PC 2024
- Fundamental
- Price
- NXTC $0.45
- PC $0.69
- Analyst Decision
- NXTC Strong Buy
- PC
- Analyst Count
- NXTC 2
- PC 0
- Target Price
- NXTC $3.50
- PC N/A
- AVG Volume (30 Days)
- NXTC 346.6K
- PC 342.0K
- Earning Date
- NXTC 07-31-2025
- PC 02-15-2025
- Dividend Yield
- NXTC N/A
- PC N/A
- EPS Growth
- NXTC N/A
- PC N/A
- EPS
- NXTC N/A
- PC N/A
- Revenue
- NXTC N/A
- PC $3,345,964.00
- Revenue This Year
- NXTC N/A
- PC N/A
- Revenue Next Year
- NXTC N/A
- PC N/A
- P/E Ratio
- NXTC N/A
- PC N/A
- Revenue Growth
- NXTC N/A
- PC N/A
- 52 Week Low
- NXTC $0.22
- PC $0.60
- 52 Week High
- NXTC $1.82
- PC $5.73
- Technical
- Relative Strength Index (RSI)
- NXTC 44.08
- PC N/A
- Support Level
- NXTC $0.45
- PC N/A
- Resistance Level
- NXTC $0.49
- PC N/A
- Average True Range (ATR)
- NXTC 0.06
- PC 0.00
- MACD
- NXTC -0.01
- PC 0.00
- Stochastic Oscillator
- NXTC 0.74
- PC 0.00
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About PC Premium Catering (Holdings) Limited Ordinary Shares
Premium Catering (Holdings) Ltd is a company that conducts its operations through its subsidiary is mainly engaged in food catering for functions, events, and workers in Singapore. Are specialized in Indian, Bangladesh, and Chinese cuisine and all its food products are Halal food which is permissible for consumption by Muslims to consume. Are an ACRA registered company and licensed by SFA to operate and process food business. Serve highquality value-packed food, company deliver's a reliable and dependable service to meet customer's daily meal requirements. The Company recognizes revenue from sales of budgeted prepared meals.